Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Metlife Inc (NYSE: MET) was $77.92 for the day, up 0.72% from the previous closing price of $77.36. In other words, the price has increased by $0.72 from its previous closing price. On the day, 2.27 million shares were traded. MET stock price reached its highest trading level at $77.975 during the session, while it also had its lowest trading level at $76.48.
Ratios:
Our analysis of MET’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on January 23, 2025, initiated with a Market Perform rating and assigned the stock a target price of $97.
On October 09, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $97.
On September 05, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $91.Barclays initiated its Overweight rating on September 05, 2024, with a $91 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 31 ’25 when Metlife 401(k) Plan Large cap bought 209 shares for $74.79 per share.
MetLife Separate Account SPI bought 360 shares of MET for $28,282 on Jul 28 ’25. On Jun 27 ’25, another insider, MetLife 401(k) Plan Trust, who serves as the Affiliate discretionary manage of the company, bought 1,024 shares for $79.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MET now has a Market Capitalization of 51818823680 and an Enterprise Value of 69535834112. As of this moment, Metlife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.21, and their Forward P/E ratio for the next fiscal year is 7.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 1.88. Its current Enterprise Value per Revenue stands at 0.952 whereas that against EBITDA is 9.594.
Stock Price History:
The Beta on a monthly basis for MET is 0.85, which has changed by 0.06666672 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, MET has reached a high of $89.05, while it has fallen to a 52-week low of $65.21. The 50-Day Moving Average of the stock is -0.02%, while the 200-Day Moving Average is calculated to be -2.94%.
Shares Statistics:
MET traded an average of 3.01M shares per day over the past three months and 4086830 shares per day over the past ten days. A total of 666.83M shares are outstanding, with a floating share count of 557.60M. Insiders hold about 16.15% of the company’s shares, while institutions hold 76.54% stake in the company. Shares short for MET as of 1753920000 were 7444390 with a Short Ratio of 2.47, compared to 1751241600 on 7061686. Therefore, it implies a Short% of Shares Outstanding of 7444390 and a Short% of Float of 1.35.
Dividends & Splits
With its trailing 12-month dividend rate of 2.203, MET has a forward annual dividend rate of 2.23. Against a Trailing Annual Dividend Yield of 0.02847725The stock’s 5-year Average Dividend Yield is 3.1. The current Payout Ratio is 36.26% for MET, which recently paid a dividend on 2025-08-05 with an ex-dividend date of 2025-08-05. Stock splits for the company last occurred on 2017-08-07 when the company split stock in a 1122:1000 ratio.
